ESSA Pharma to Participate in the Guggenheim Healthcare Talks 5th Annual Oncology Conference

ESSA Pharma to Participate in the Guggenheim Healthcare Talks 5th Annual Oncology Conference

Canada NewsWire

SOUTH SAN FRANCISCO, California and VANCOUVER, Canada, Feb. 2, 2023 /CNW/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced that the Company will participate in a fireside chat at the Guggenheim Healthcare Talks 5th Annual Oncology Conference in New York City on Thursday, February 9, 2023, at 9:00 a.m. Eastern Time.

David R. Parkinson, President and Chief Executive Officer of ESSA Pharma; Peter Virsik, ESSA's Chief Operating Officer; and David S. Wood, ESSA's Chief Financial Officer, will host and participate in one-on-one meetings.

A live webcast of the presentation can be accessed in the Investors/Events & Presentations section of ESSA's website at www.essapharma.com. An archived replay of the event will be available for 30 days.

About ESSA Pharma Inc.

ESSA is a clinical-stage pharmaceutical company focused on developing novel and proprietary therapies for the treatment of patients with prostate cancer. For more information, please visit www.essapharma.com and follow us on Twitter under @ESSAPharma.

Cision View original content:https://www.prnewswire.com/news-releases/essa-pharma-to-participate-in-the-guggenheim-healthcare-talks-5th-annual-oncology-conference-301737785.html

SOURCE ESSA Pharma Inc

Cision View original content: http://www.newswire.ca/en/releases/archive/February2023/02/c2470.html

Copyright CNW Group 2023